LaunchCyte
Overview
LaunchCyte is a venture capital firm specializing in early-stage investments in life sciences companies. Founded in 2000 and based in Pittsburgh, Pennsylvania, the firm focuses on commercializing university-developed technologies in sectors such as healthcare, lighting, and display industries. LaunchCyte sources technologies through a network of university partners and other contacts, evaluating them with a science staff trained in business, emphasizing high-risk, early-stage technology concepts. The firm finances and helps design proofs of concept, the development of intellectual property strategy, and the launch of initial operations. At each stage, LaunchCyte is guided by its board of directors. The firm's portfolio includes companies like Knopp Biosciences, Crystalplex, Immunetrics, and Reaction Biology. LaunchCyte has been involved in several funding rounds, including a $12,443,000 investment in Knopp Biosciences on September 30, 2015, and a $150,000 investment in Crystalplex on December 31, 2012. The firm is actively seeking new investments and continues to support the growth of innovative life sciences companies. LaunchCyte's investment strategy involves identifying promising technologies from research universities and commercializing them into market-facing companies or licensed products. The firm provides advisory and operational support to convert university-developed technologies into market-facing companies or licensed products. LaunchCyte also offers portfolio management and strategic oversight for a portfolio of early-stage companies across healthcare, lighting, and display sectors. The firm's expertise areas include technology commercialization, university technology transfer, startup incubation, and portfolio management. LaunchCyte's key technologies encompass healthcare, lighting, and display technologies. The firm is committed to fostering innovation and supporting the growth of life sciences companies through its comprehensive investment approach. With a focus on high-risk, early-stage technology concepts, LaunchCyte plays a pivotal role in bringing innovative solutions to market. The firm's involvement in various funding rounds demonstrates its commitment to supporting the growth of life sciences companies. LaunchCyte's portfolio reflects its dedication to advancing technologies in healthcare, lighting, and display industries. The firm's strategic oversight and support have been instrumental in the development and success of its portfolio companies. LaunchCyte continues to seek out and invest in promising technologies, contributing to the advancement of the life sciences sector.
Investment Focus
- High-risk, early-stage technology concepts
- University-developed technologies
- Healthcare, lighting, and display sectors
Portfolio Companies
Reach LaunchCyte directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about LaunchCyte
What sectors does LaunchCyte invest in?
LaunchCyte invests in Healthcare, Lighting and Display, and is based in Pittsburgh, United States. LaunchCyte is listed as a venture capital in the ConnectSafely investor database.
What stage does LaunchCyte invest at?
LaunchCyte backs companies at Seed and Early Stage, writing cheques of 1M - 12.4M.
Which regions does LaunchCyte invest in?
LaunchCyte invests across United States.
Who are the partners at LaunchCyte?
Team members listed for LaunchCyte include Babs Carryer (Co-founder; past President; Secretary; Board Director) and Tom Petzinger (CEO/President/Founder/Chairman).
What companies has LaunchCyte invested in?
LaunchCyte's portfolio includes Reaction Biology, Knopp Biosciences, Crystalplex and Immunetrics.
How do I contact LaunchCyte?
LaunchCyte's contact details — including phone and LinkedIn — are listed in the ConnectSafely investor database, along with its website and the LinkedIn profiles of its partners.
Last updated · Source: ConnectSafely investor database